首页 | 官方网站   微博 | 高级检索  
     

前列腺素E1联合痰热清注射液治疗急性黄疸型肝炎疗效研究
引用本文:姜捷,孙明晓,张兆清,刘运龙.前列腺素E1联合痰热清注射液治疗急性黄疸型肝炎疗效研究[J].临床肝胆病杂志,2009,25(1):52-54.
作者姓名:姜捷  孙明晓  张兆清  刘运龙
作者单位:聊城市传染病医院,山东聊城,252000
摘    要:目的观察前列腺素E1联合痰热清注射液治疗急性黄疸型肝炎疗效。方法将156例急性黄疸型肝炎患者分为2组,治疗组84例在常规治疗的基础上应用前列腺素E1和痰热清注射液,对照组72例患者在常规治疗的基础上给予茵栀黄注射液。疗程为1个月。结果治疗结束时治疗组临床症状、肝功能指标等明显好于对照组(P〈0.05)。结论前列腺素E1联合痰热清注射液能有效治疗急性黄疸型肝炎,安全性好。

关 键 词:急性黄疸型肝炎  前列腺素E1  痰热清注射液

Observation of clinical efficacy of Alprostadil E_1 and Tanreqing in acute icterichepatitis.
JIANG Jie,SUN Ming-xiao,ZHANG Zhao-qing,et al..Observation of clinical efficacy of Alprostadil E_1 and Tanreqing in acute icterichepatitis.[J].Chinese Journal of Clinical Hepatology,2009,25(1):52-54.
Authors:JIANG Jie  SUN Ming-xiao  ZHANG Zhao-qing  
Affiliation:Liaocheng Hospital of Infectious Disease;Shandong 252000;China
Abstract:Objective To evaluate the clinical efficacy of Alprostadil E1 and Tanreqing in acute icterichepatitis.Methods 156 acute icterichepatitis were randomly divided into treat group and control group.Patients in treat group(84) were treated with Alprostadil E1 and Tanreqing for one month.However,patients in control group(72) with Yinzhihuang for one month.Patients in both groups were treated with conventional treatment.Results Clinical symptoms and liver function of the patients in treat group were better than th...
Keywords:acute icterichepatitis  Alprostadil E_1  Tanreqing  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号